Company News Summary
CSL Provides Update on Acquisition of Vifor Pharma
03 Mar 2022 | 18:23:00 | Associate analysts | Increase | Decrease | 
Original announcement: Update on Acquisition of Vifor Pharma
CSL advised that the main offer period for the public tender offer to acquire all publicly held shares of Vifor Pharma (Vifor) has closed, with 74% of Vifor shares tendered. The Company stated that it has received support from Vifor shareholders for the acquisition and plans to waive the original 80% acceptance rate condition and to declare the offer successful. Following this, a tender period for subsequent acceptance of the offer will commence on 9 March 2022 and run through until 22 March 2022.
See more ASX300 News Announcements